Cargando…
Validity of the MPTP-Treated Mouse as a Model for Parkinson’s Disease
Parkinson’s disease (PD) is characterized by dopaminergic (DA) neuron death in the substantia nigra (SN) and subsequent striatal adaptations. Mice treated with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine (MPTP) are widely used as a model for PD. To assess the validity of the MPTP m...
Autores principales: | Klemann, Cornelius J. H. M., Martens, Gerard J. M., Poelmans, Geert, Visser, Jasper E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789200/ https://www.ncbi.nlm.nih.gov/pubmed/25676140 http://dx.doi.org/10.1007/s12035-015-9103-8 |
Ejemplares similares
-
Physical Exercise Modulates L-DOPA-Regulated Molecular Pathways in the MPTP Mouse Model of Parkinson’s Disease
por: Klemann, Cornelius J. H. M., et al.
Publicado: (2017) -
Shared genetic etiology between Parkinson’s disease and blood levels of specific lipids
por: Xicoy, Helena, et al.
Publicado: (2021) -
Integrated molecular landscape of Parkinson’s disease
por: Klemann, C. J. H. M., et al.
Publicado: (2017) -
The Neuroprotective Effects of Cinnamic Aldehyde in an MPTP Mouse Model of Parkinson’s Disease
por: Bae, Woom-Yee, et al.
Publicado: (2018) -
Dynamic Changes in the Nigrostriatal Pathway in the MPTP Mouse Model of Parkinson's Disease
por: Huang, Dongping, et al.
Publicado: (2017)